Search

everythinglearnresearchcommunity

for

Search:↓

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

A man developed skin issues from cancer medication, which improved with specific treatments.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

Teicoplanin may help treat hair loss by reducing androgen receptors and boosting hair cell growth.

Oral tofacitinib effectively regrows hair in children with alopecia areata without major side effects.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

Topical oligonucleotide therapy targets hair follicles effectively.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Glioma treatment may improve with new therapies and technologies.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

The formulated gel is a promising treatment for alopecia areata.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Trichostatin A helps restore hair-growing ability in skin cells used for hair regeneration.

Tofacitinib helped a woman with total-body hair loss grow her hair back.